Intrasense and Vidi, the leading cooperative network of medical imaging groups in France, signed an agreement on January 30th, 2021 to reference Myrian® solutions.

Intrasense is pleased to present the new version 2.9, with a focus on new clinical features.

Intrasense announces its 2020 IFRS Group consolidated annual results.

Intrasense and MeVis Medical Solutions AG specialized in
the development of clinical applications integrating artificial intelligence, announce a global partnership in the field of lung diseases.

Intrasense announces the publication of its half year liquidity contract signed with TSAF – Tradition Securities And Futures.

Intrasense strengthens its management team with the appointment of Khalil Filali as Group Chief Business Officer.

Intrasense™ announces the end of the BCS (Bond Convertible into Shares) financing contract concluded with the Luxembourgish fund European High Growth Opportunities Securitization Fund (EHGO).

Intrasense announces the appointment of Lionel Seltz as Group Chief Financial Officer. Financial expertise and international background in structuring growing companies to meet the new corporate development requirements.

Intrasense is pleased to present the new version 2.8 of its visualization platform with many new features, from clinical applications to improved workflow.

Intrasense announces following a Board meeting on October 8th, 2020, a partial renewal and strengthening of its composition. Michèle Lesieur is coopted as administrator and appointed Chairman of the Board. Anne Larpin is coopted as administrator of the company. The ratification of these cooptations will be submitted to the next ordinary general meeting.